Related references
Note: Only part of the references are listed.Crystallographic screening using ultra-low-molecular-weight ligands to guide drug design
Marc O'Reilly et al.
DRUG DISCOVERY TODAY (2019)
FragLites-Minimal, Halogenated Fragments Displaying Pharmacophore Doublets. An Efficient Approach to Druggability Assessment and Hit Generation
Daniel J. Wood et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
High-resolution structure determination of sub-100 kDa complexes using conventional cryo-EM
Mark A. Herzik et al.
NATURE COMMUNICATIONS (2019)
Rapid Covalent-Probe Discovery by Electrophile-Fragment Screening
Efrat Resnick et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
A 3.8 Å resolution cryo-EM structure of a small protein bound to an imaging scaffold
Yuxi Liu et al.
NATURE COMMUNICATIONS (2019)
A Structure-Based Drug Discovery Paradigm
Maria Batool et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Discovery of N-(1-Acryloylazetidin-3-yl)-2-(1H-indol-1-yl)acetamides as Covalent Inhibitors of KRASG12C
Youngsook Shin et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Discovery of covalent enzyme inhibitors using virtual docking of covalent fragments
Sandipan Roy Chowdhury et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Fragment-to-Lead Medicinal Chemistry Publications in 2017
Paul N. Mortenson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Fragment-Based Covalent Ligand Screening Enables Rapid Discovery of Inhibitors for the RBR E3 Ubiquitin Ligase HOIP
Henrik Johansson et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
Enabling synthesis in fragment-based drug discovery by reactivity mapping: photoredox-mediated cross-dehydrogenative heteroarylation of cyclic amines
Rachel Grainger et al.
CHEMICAL SCIENCE (2019)
Fragment-Based Drug Discovery: Advancing Fragments in the Absence of Crystal Structures
Daniel A. Erlanson et al.
CELL CHEMICAL BIOLOGY (2019)
Fragment-to-Lead Medicinal Chemistry Publications in 2016
Christopher N. Johnson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Fragment-Based Discovery of Pyrimido[1,2-b]indazole PDE10A Inhibitors
Ayaka Chino et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2018)
Integrated Strategy for Lead Optimization Based on Fragment Growing: The Diversity-Oriented-Target-Focused-Synthesis Approach
Laurent Hoffer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Structure determination of protein-ligand complexes by NMR in solution
Julien Orts et al.
METHODS (2018)
Current NMR Techniques for Structure-Based Drug Discovery
Toshihiko Sugiki et al.
MOLECULES (2018)
Organic synthesis provides opportunities to transform drug discovery
David C. Blakemore et al.
NATURE CHEMISTRY (2018)
Cryo-EM in drug discovery: achievements, limitations and prospects
Jean-Paul Renaud et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Fragment-to-Lead Medicinal Chemistry Publications in 2015
Christopher N. Johnson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Discovery and Pharmacological Characterization of JNJ-42756493 (Erdafitinib), a Functionally Selective Small-Molecule FGFR Family Inhibitor
Timothy P. S. Perera et al.
MOLECULAR CANCER THERAPEUTICS (2017)
A multi-crystal method for extracting obscured crystallographic states from conventionally uninterpretable electron density
Nicholas M. Pearce et al.
NATURE COMMUNICATIONS (2017)
Cryo-EM structure of haemoglobin at 3.2 Å determined with the Volta phase plate
Maryam Khoshouei et al.
NATURE COMMUNICATIONS (2017)
Proper modelling of ligand binding requires an ensemble of bound and unbound states
Nicholas M. Pearce et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2017)
Gentle, fast and effective crystal soaking by acoustic dispensing
Patrick M. Collins et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2017)
Protein-ligand binding affinity determination by the waterLOGSY method: An optimised approach considering ligand rebinding
Renjie Huang et al.
SCIENTIFIC REPORTS (2017)
The identification of a novel lead class for phosphodiesterase 2 inhibition by fragment-based drug design
Ashley B. Forster et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Current advances in synchrotron radiation instrumentation for MX experiments
Robin L. Owen et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2016)
Design Principles for Fragment Libraries: Maximizing the Value of Learnings from Pharma Fragment-Based Drug Discovery (FBDD) Programs for Use in Academia
Gyoergy M. Keseru et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Native Mass Spectrometry in Fragment-Based Drug Discovery
Liliana Pedro et al.
MOLECULES (2016)
Twenty years on: the impact of fragments on drug discovery
Daniel A. Erlanson et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
The ways and means of fragment-based drug design
Bradley C. Doak et al.
PHARMACOLOGY & THERAPEUTICS (2016)
An Automated Microscale Thermophoresis Screening Approach for Fragment-Based Lead Discovery
Pawel Linke et al.
JOURNAL OF BIOMOLECULAR SCREENING (2016)
FEI's direct electron detector developments: Embarking on a revolution in cryo-TEM
Maarten Kuijper et al.
JOURNAL OF STRUCTURAL BIOLOGY (2015)
Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor
W. D. Tap et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
A Fragment-Based Method to Discover Irreversible Covalent Inhibitors of Cysteine Proteases
Stefan G. Kathman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
MicroScale Thermophoresis: Interaction analysis and beyond
Moran Jerabek-Willemsen et al.
JOURNAL OF MOLECULAR STRUCTURE (2014)
Efficient exploration of chemical space by fragment-based screening
Richard J. Hall et al.
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2014)
Ultrastable gold substrates for electron cryomicroscopy
Christopher J. Russo et al.
SCIENCE (2014)
Automation in biological crystallization
Patrick Shaw Stewart et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2014)
Expanding medicinal chemistry space
Andy Barker et al.
DRUG DISCOVERY TODAY (2013)
Fragment-based hit identification: thinking in 3D
Andrew D. Morley et al.
DRUG DISCOVERY TODAY (2013)
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
Jonathan M. Ostrem et al.
NATURE (2013)
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Andrew J. Souers et al.
NATURE MEDICINE (2013)
A three-stage biophysical screening cascade for fragment-based drug discovery
Ellene H. Mashalidis et al.
NATURE PROTOCOLS (2013)
The 'rule of three' for fragment-based drug discovery: where are we now?
Harren Jhoti et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Integrated biophysical approach to fragment screening and validation for fragment-based lead discovery
Hernani Leonardo Silvestre et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Using chemical shift perturbation to characterise ligand binding
Mike P. Williamson
PROGRESS IN NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY (2013)
Spotiton: A prototype for an integrated inkjet dispense and vitrification system for cryo-TEM
Tilak Jain et al.
JOURNAL OF STRUCTURAL BIOLOGY (2012)
Technical and practical aspects of 19F NMR-based screening: toward sensitive high-throughput screening with rapid deconvolution
Claudio Dalvit et al.
MAGNETIC RESONANCE IN CHEMISTRY (2012)
Vemurafenib: the first drug approved for BRAF-mutant cancer
Gideon Bollag et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Data processing and analysis with the autoPROC toolbox
Clemens Vonrhein et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2011)
Saturation-Transfer Difference (STD) NMR: A Simple and Fast Method for Ligand Screening and Characterization of Protein Binding
Aldino Viegas et al.
JOURNAL OF CHEMICAL EDUCATION (2011)
Assessing the lipophilicity of fragments and early hits
Paul N. Mortenson et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2011)
Impact of high-throughput screening in biomedical research
Ricardo Macarron et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Molecular obesity, potency and other addictions in drug discovery
Michael M. Hann
MEDCHEMCOMM (2011)
Fast Two-Dimensional NMR Spectroscopy of High Molecular Weight Protein Assemblies
Carlos Amero et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Theoretical analysis of the competition ligand-based NMR experiments and selected applications to fragment screening and binding constant measurements
Claudio Dalvit
CONCEPTS IN MAGNETIC RESONANCE PART A (2008)
The influence of drug-like concepts on decision-making in medicinal chemistry
Paul D. Leeson et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Why molecules move along a temperature gradient
Stefan Duhr et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Structure-activity relationships by interligand NOE-based design and synthesis of antiapoptotic compounds targeting Bid
Barbara Becattini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Applications of ESI-MS in drug discovery: interrogation of noncovalent complexes
Steven A. Hofstadler et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Fragment-based lead discovery using X-ray crystallography
MJ Hartshorn et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
High-throughput protein crystallography and drug discovery
I Tickle et al.
CHEMICAL SOCIETY REVIEWS (2004)
Fluorine-NMR competition binding experiments for high-throughput screening of large compound mixtures
C Dalvit et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2002)
The consequences of translational and rotational entropy lost by small molecules on binding to proteins
CW Murray et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2002)
WaterLOGSY as a method for primary NMR screening: Practical aspects and range of applicability
C Dalvit et al.
JOURNAL OF BIOMOLECULAR NMR (2001)
Molecular complexity and its impact on the probability of finding leads for drug discovery
MM Hann et al.
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES (2001)
Drug-like properties and the causes of poor solubility and poor permeability
CA Lipinski
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2000)
Share Paper
